Lingfei Xu

914 total citations
17 papers, 764 citations indexed

About

Lingfei Xu is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Lingfei Xu has authored 17 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Lingfei Xu's work include Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (5 papers) and Adenosine and Purinergic Signaling (4 papers). Lingfei Xu is often cited by papers focused on Virus-based gene therapy research (12 papers), RNA Interference and Gene Delivery (5 papers) and Adenosine and Purinergic Signaling (4 papers). Lingfei Xu collaborates with scholars based in United States, China and United Kingdom. Lingfei Xu's co-authors include Katherine P. Ponder, Mark E. Haskins, Mark S. Sands, Cuihua Gao, N. Matthew Ellinwood, Dwight A. Bellinger, Timothy C. Nichols, Terence R. Flotte, Sihong Song and Barry J. Byrne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Lingfei Xu

17 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfei Xu United States 12 466 393 238 132 121 17 764
Amy Poirier United States 11 587 1.3× 590 1.5× 88 0.4× 151 1.1× 118 1.0× 13 910
Thomas O’Malley United States 12 269 0.6× 220 0.6× 373 1.6× 43 0.3× 190 1.6× 16 615
Stefania Merella Italy 8 399 0.9× 484 1.2× 89 0.4× 163 1.2× 42 0.3× 9 734
Georg Bohn Germany 9 375 0.8× 455 1.2× 167 0.7× 110 0.8× 48 0.4× 14 920
Jeremy P. Springhorn United States 13 134 0.3× 444 1.1× 88 0.4× 101 0.8× 39 0.3× 17 936
Gabriella Cotugno Italy 17 316 0.7× 383 1.0× 152 0.6× 184 1.4× 135 1.1× 37 792
Albert Ribera Spain 16 274 0.6× 346 0.9× 411 1.7× 31 0.2× 281 2.3× 24 911
Annalisa Lattanzi Italy 10 153 0.3× 420 1.1× 137 0.6× 30 0.2× 45 0.4× 15 578
Katayoun Ayasoufi United States 18 143 0.3× 274 0.7× 40 0.2× 256 1.9× 87 0.7× 39 1.0k
Stuart Ellison United Kingdom 14 109 0.2× 250 0.6× 147 0.6× 36 0.3× 59 0.5× 27 552

Countries citing papers authored by Lingfei Xu

Since Specialization
Citations

This map shows the geographic impact of Lingfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Xu more than expected).

Fields of papers citing papers by Lingfei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Xu. The network helps show where Lingfei Xu may publish in the future.

Co-authorship network of co-authors of Lingfei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Xu. A scholar is included among the top collaborators of Lingfei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Xu. Lingfei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ma, Xiucui, et al.. (2008). Neonatal Intravenous Injection of a Gammaretroviral Vector Has a Low Incidence of Tumor Induction in Mice. Human Gene Therapy. 19(11). 1317–1323. 3 indexed citations
2.
Spitzer, Dirk, Xiaobo Wu, Xiucui Ma, et al.. (2006). Cutting Edge: Treatment of Complement Regulatory Protein Deficiency by Retroviral In Vivo Gene Therapy. The Journal of Immunology. 177(8). 4953–4956. 10 indexed citations
3.
Xu, Lingfei, Mark E. Haskins, Timothy C. Nichols, et al.. (2006). Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice. Thrombosis Research. 120(2). 269–280. 32 indexed citations
4.
Wang, Bin, Thomas O’Malley, Lingfei Xu, et al.. (2005). Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs. Molecular Genetics and Metabolism. 87(1). 8–21. 33 indexed citations
5.
Xu, Lingfei, et al.. (2005). Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy. Proceedings of the National Academy of Sciences. 102(17). 6080–6085. 62 indexed citations
6.
Xu, Lingfei, Mark S. Sands, Bin Wang, et al.. (2004). In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice. Molecular Therapy. 10(1). 37–44. 18 indexed citations
7.
8.
Liu, Yuli, Lingfei Xu, Anne K. Hennig, et al.. (2004). Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Molecular Therapy. 11(1). 35–47. 73 indexed citations
9.
Xu, Dehua, Lei Cao, Lingfei Xu, et al.. (2003). Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene.. PubMed. 35(12). 1066–71. 3 indexed citations
10.
Chen, Sifan, et al.. (2003). Behavioral correction of Parkinsonian rats following the transplantation of immortalized fibroblasts genetically modified with TH and GCH genes. Parkinsonism & Related Disorders. 9. 91–97. 13 indexed citations
11.
Zhang, Jun, Lingfei Xu, Mark E. Haskins, & Katherine P. Ponder. (2003). Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Blood. 103(1). 143–151. 41 indexed citations
12.
Xu, Lingfei, Cuihua Gao, Mark S. Sands, et al.. (2003). Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B. Blood. 101(10). 3924–3932. 82 indexed citations
13.
14.
Xu, Lingfei, et al.. (2002). Evaluation of Pathological Manifestations of Disease in Mucopolysaccharidosis VII Mice after Neonatal Hepatic Gene Therapy. Molecular Therapy. 6(6). 745–758. 59 indexed citations
15.
Ponder, Katherine P., John R. Melniczek, Lingfei Xu, et al.. (2002). Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proceedings of the National Academy of Sciences. 99(20). 13102–13107. 132 indexed citations
16.
17.
Xu, Dehua, Xianwen Chen, Lingfei Xu, et al.. (2001). Treatment of Parkinson's Disease by Genetically Modified Immortalized Fibroblasts.. PubMed. 33(1). 117–122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Poirier Breakdown of academic impact, for papers by Thomas O’Malley Breakdown of academic impact, for papers by Stefania Merella Breakdown of academic impact, for papers by Georg Bohn Breakdown of academic impact, for papers by Jeremy P. Springhorn Breakdown of academic impact, for papers by Gabriella Cotugno Breakdown of academic impact, for papers by Albert Ribera Breakdown of academic impact, for papers by Annalisa Lattanzi Breakdown of academic impact, for papers by Katayoun Ayasoufi Breakdown of academic impact, for papers by Stuart Ellison
Rankless by CCL
2026